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Objectives:  Placental proton magnetic resonance spectroscopy ( 1 H MRS) is a newly 
emerging technique with the potential to noninvasively assess the function of the 
placenta in vivo. Previous studies utilising this technique have been limited. This study 
aimed to investigate whether this tool could be feasible for routine clinical use. 
Design:  Prospective cohort study in a tertiary referral clincial MRI center. 
Procedure adopted to reflect clinical practice 
Method: In utero placental MR spectra were obtained from women 
(n=43) referred for fetal MRI following abnormal ultrasound scans. Participants were of 
varying gestational age (GA) and exhibited a wide range of fetal pathologies unrelated to 
placental function. Spectra quality was assessed both qualitatively and quantitatively, 
with the potential influence of GA and placental Grannum grade (GG) also considered. 
Results: Almost 75% of spectra obtained were considered good quality, with 
substantial agreement between assessors (Fleiss Kappa: K=0.646) and were therefore 
considered suitable for diagnostic interpretation. Neither GA (Anova: P>0.05) nor GG 
significantly influenced visual spectra quality. Signal-to- noise ratio also appeared 
unaffected by the GA (Regression: P>0.05) and GG (Anova: P>0.05) of participants. Lipid 
contamination due to fetal movement negatively affected spectra obtained from 
participants of low GA. No visible trend was observed between GA or GG and spectral 
metabolites. 
Conclusions: In vivo placental 1H MRS is feasible in routine clinical practice and 
warrants further investigation. The spectra obtained do not appear to be influenced by 
either the GA or GG in terms of quality or spectral metabolites. Future studies 
establishing metabolite thresholds profiles for conditions, and confirming our 
conclusions regarding the influence of potential confounding variables would be 
beneficial. 
 
